Earnings History Data for Matinas Biopharma Holdings, Inc. (MTNB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Matinas Biopharma Holdings, Inc.

Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
08-11-2021 PM 6:30 AM ET
(Nov 8)
MTNB Matinas Biopharma Holdings, Inc. 233.54 -0.03 -0.03 -0.03 Matinas Biopharma EPS misses by $0.01, misses on revenue
[11/8/2021 6:37 AM]
0.9951 -0.07 
(-7.00%)
1.05 -0.02 
(-1.87%)
0.67 - 2.22 2,056,563 1,260,000 113,751
10-08-2021 PM 6:30 AM ET
(Aug 10)
MTNB Matinas Biopharma Holdings, Inc. 158.95 -0.02 -0.02 -0.03 Matinas Biopharma EPS beats by $0.01
[8/10/2021 6:33 AM]
0.7359 -0.03 
(-4.42%)
0.75 -0.02 
(-2.20%)
0.66 - 2.22 1,377,798 900,000 230,693
10-05-2021 PM 6:30 AM ET
(May 10)
MTNB Matinas Biopharma Holdings, Inc. 164.24 -0.03 -0.03 -0.03 Matinas Biopharma EPS and revenue in-line
[5/10/2021 6:40 AM]
0.7648 -0.03 
(-3.26%)
0.83 0.04 
(4.98%)
0.66 - 2.22 1,382,473 1,320,000 33,677
29-03-2021 PM 7:00 AM ET
(Mar 29)
MTNB Matinas Biopharma Holdings, Inc. 223.60 -0.03 -0.03 -0.04 Matinas Biopharma EPS in-line, misses on revenue
[3/29/2021 6:35 AM]
1.08 -0.04 
(-3.57%)
1.09 -0.03 
(-2.68%)
0.49 - 2.22 1,435,674 1,650,000 46,216
06-11-2020 PM 6:30 AM ET
(Nov 6)
MTNB Matinas Biopharma Holdings, Inc. 167.48 -0.03 -0.03 -0.03 Matinas Biopharma EPS in-line, beats on revenue
[11/6/2020 6:42 AM]
0.8446 0.0 
(-0.09%)
0.86 0.01 
(1.73%)
0.49 - 2.49 1,386,381 1,070,976 27,744
10-08-2020 AH 4:05 PM ET
(Aug 10)
MTNB Matinas Biopharma Holdings, Inc. 187.14 -0.03 -0.03 -0.03 Matinas Biopharma EPS in-line, misses on revenue
[8/10/2020 4:27 PM]
0.8650 -0.06 
(-6.28%)
0.9010 -0.02 
(-2.38%)
0.49 - 2.49 2,313,776 3,361,721 87,275